Related references
Note: Only part of the references are listed.Two Independent Mechanisms Promote Expression of an N-terminal Truncated USP18 Isoform with Higher DeISGylation Activity in the Nucleus
Christoph Burkart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus
Nadine Honke et al.
NATURE IMMUNOLOGY (2012)
USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inflammation and apoptosis
I. Santin et al.
CELL DEATH & DISEASE (2012)
Implication of the Toll-Like Receptor 4 Pathway in the Response to Interferon-β in Multiple Sclerosis
Marta F. Bustamante et al.
ANNALS OF NEUROLOGY (2011)
Usp18 Regulates Epidermal Growth Factor (EGF) Receptor Expression and Cancer Cell Survival via MicroRNA-7
Jason E. Duex et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Interferon-Stimulated Gene 15 and the Protein ISGylation System
Dongxian Zhang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis
S. Malhotra et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Search for Specific Biomarkers of IFNβ Bioactivity in Patients with Multiple Sclerosis
Sunny Malhotra et al.
PLOS ONE (2011)
A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
M. Comabella et al.
BRAIN (2009)
Alpha Interferon Induces Long-Lasting Refractoriness of JAK-STAT Signaling in the Mouse Liver through Induction of USP18/UBP43
Magdalena Sarasin-Filipowicz et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
SNP analysis to results (SNPator):: a web-based environment oriented to statistical genomics analyses upon SNP data
Carlos Morcillo-Suarez et al.
BIOINFORMATICS (2008)
Identification of a Novel Risk Locus for Multiple Sclerosis at 13q31.3 by a Pooled Genome-Wide Scan of 500,000 Single Nucleotide Polymorphisms
Manuel Comabella et al.
PLOS ONE (2008)
Microarray analysis reveals that Type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages
Weiguo Zou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity
Oxana A. Malakhova et al.
EMBO JOURNAL (2006)
Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients
J Río et al.
ANNALS OF NEUROLOGY (2006)
TRANSFAC (R) and its module TRANSCompel (R): transcriptional gene regulation in eukaryotes
V. Matys et al.
NUCLEIC ACIDS RESEARCH (2006)
Impairment of membrane markers on peripheral blood mononuclear cells and imbalance of cytokine secretion in the pathogenesis of multiple sclerosis active phases
V Sofo et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2005)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
MH Barnett et al.
ANNALS OF NEUROLOGY (2004)
Protein ISGylation modulates the JAK-STAT signaling pathway
OA Malakhova et al.
GENES & DEVELOPMENT (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
A new statistical method for haplotype reconstruction from population data
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)